指南与共识流行病学与生物统计医学教育与科研方法

特应性湿疹治疗(TREAT)注册工作组:用于确定国家特应性湿疹注册中心核心域和域条目的国际Delphi exercise方案

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
指南 / 共识 · Trials · 2017-02-27

该方案由国际TREAT注册工作组开展,采用eDelphi方法,邀请医生、护士、非临床研究者、患者、行业及监管机构代表共六类利益相关者,经三轮在线评分和最终共识会议,就具有研究导向、收集儿童和成人光疗及系统性免疫调节治疗数据的特应性湿疹患者注册中心的核心域和域条目达成共识。

要点

  • 中重度特应性湿疹常用光疗或系统性免疫调节治疗,但现有循证证据有限。
  • 患者注册中心可填补证据缺口,统一核心域和域条目有助于跨注册中心直接比较和数据共享。
  • 该eDelphi计划三轮在线评分加最终共识会议,邀请六类利益相关者参与。

核心结论

  • 确定特应性湿疹患者注册中心统一的核心域和域条目,将提高单个注册中心的效用,并更深入洞察光疗和系统性免疫调节治疗的有效性、安全性和成本效果,以指导跨皮肤科中心及跨国界的临床管理。

研究设计与样本

  • 国际TREAT注册工作组开展的eDelphi研究,方案已注册于COMET数据库。
  • 邀请六类利益相关者参与:医生、护士、非临床研究者、患者、行业代表和监管机构代表。
  • eDelphi包括三轮序贯在线评分,要求参与者对每个拟议域和域条目的重要性进行评分。
  • 第一轮参与者可在拟议列表中添加域和域条目。
  • 将举行由各类利益相关者代表参加的最终共识会议。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with moderate-to-severe atopic eczema (AE) often require photo- or systemic immunomodulatory therapies to induce disease remission and maintain long-term control. The current evidence to guide clinical management is small, despite the frequent and often off-label use of these treatments. Registries of patients on photo- and systemic immunomodulatory therapies could fill this gap, and the collection of a core set concerning these therapies in AE will allow direct comparisons across registries as well as data sharing and pooling. Using an eDelphi approach, the international TREatment of ATopic eczema (TREAT) Registry Taskforce aims to seek consensus between key stakeholders internationally on a core set of domains and domain items for AE patient registries with a research focus that collect data of children and adults on photo- and systemic immunomodulatory therapies. METHODS/DESIGN: Participants from six stakeholder groups will be invited: doctors, nurses, non-clinical researchers, patients, as well as industry and regulatory body representatives. The eDelphi will comprise three sequential online rounds, requesting participants to rate the importance of each proposed domain and domain items. Participants will be able to add domains and domain items to the proposed list in round 1. A final consensus meeting will be held with representatives of each stakeholder group. DISCUSSION: Identifying a uniform core set of domains and domain items to be captured by AE patient registries will increase the utility of individual registries, and provide greater insight into the effectiveness, safety and cost-effectiveness of photo- and systemic immunomodulatory therapies to guide clinical management across dermatology centres and country borders. TRIAL REGISTRATION: Not applicable. This eDelphi study was registered in the Core Outcome Measures for Effectiveness Trials (COMET) database.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gerbens LA, Boyce AE, Wall D, et al. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries. Trials. 2017. PMID: 28241851. doi:10.1186/s13063-016-1765-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。